Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000672102 | SCV000797167 | likely pathogenic | Usher syndrome type 2A; Retinitis pigmentosa 39 | 2018-01-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001231865 | SCV001404401 | pathogenic | not provided | 2019-08-21 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). This variant has been observed in an individual affected with retinitis pigmentosa (PMID: 26496393). ClinVar contains an entry for this variant (Variation ID: 556144). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Trp2523*) in the USH2A gene. It is expected to result in an absent or disrupted protein product. |
Genome- |
RCV003453343 | SCV004183233 | likely pathogenic | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003453342 | SCV004183234 | likely pathogenic | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003453343 | SCV004206386 | pathogenic | Retinitis pigmentosa 39 | 2022-10-01 | criteria provided, single submitter | clinical testing |